Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shepherd

Showing results (1081-1090 of 1,281) with videos related to

Pageof 129
Sort By:
JTO Clinical and Research Reports|April 17, 2025
Myasthenia Gravis in Patients Treated With Immune Checkpoint InhibitorsAbdulrahman Alghabban, Lucy Corke, Hans Katzberg, et al.
Science (New York, N.Y.)|February 24, 2018
Structural principles that enable oligomeric small heat-shock protein paralogs to evolve distinct functionsGeorg K A Hochberg, Dale A Shepherd, Erik G Marklund, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2017
Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant ChemotherapyFrances A Shepherd, Benjamin Lacas, Gwénaël Le Teuff, et al.
Cancer Research|May 31, 2002
Molecular profiling of non-small cell lung cancer and correlation with disease-free survivalDennis A Wigle, Igor Jurisica, Niki Radulovich, et al.
Therapeutic Advances in Medical Oncology|October 30, 2025
A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastasesMaisam Makarem, Tuan Hoang, Mitchell J Elliott, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 23, 2016
Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled AnalysisXiaoli Ma, Gwénaël Le Teuff, Benjamin Lacas, et al.
Clinical Lung Cancer|September 17, 2021
Treatment Patterns and Outcomes of Patients With Advanced Pleural Mesothelioma at an Academic Referral CentreSabine Schmid, Luna Zhan, Kristen Dietrich, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Repeat Next-Generation Sequencing (15-Gene Panel) in Unifocal, Synchronous, and Metachronous Non-Small-Cell Lung Cancer-A Single-Center ExperienceShelley Kuang, Kaitlin Chen, Sachin Sayal, et al.
Breast Cancer Research : BCR|July 18, 2012
Height, adiposity and body fat distribution and breast density in young womenJoanne F Dorgan, Catherine Klifa, John A Shepherd, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 2, 2013
Epidermal growth factor receptor inhibition in lung cancer: status 2012Fred R Hirsch, Pasi A Jänne, Wilfried E Eberhardt, et al.
Pageof 129

Showing results (1081-1090 of 1,281) with videos related to

Sort By:
Pageof 129
JTO Clinical and Research Reports|April 17, 2025
Myasthenia Gravis in Patients Treated With Immune Checkpoint InhibitorsAbdulrahman Alghabban, Lucy Corke, Hans Katzberg, et al.
Science (New York, N.Y.)|February 24, 2018
Structural principles that enable oligomeric small heat-shock protein paralogs to evolve distinct functionsGeorg K A Hochberg, Dale A Shepherd, Erik G Marklund, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2017
Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant ChemotherapyFrances A Shepherd, Benjamin Lacas, Gwénaël Le Teuff, et al.
Cancer Research|May 31, 2002
Molecular profiling of non-small cell lung cancer and correlation with disease-free survivalDennis A Wigle, Igor Jurisica, Niki Radulovich, et al.
Therapeutic Advances in Medical Oncology|October 30, 2025
A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastasesMaisam Makarem, Tuan Hoang, Mitchell J Elliott, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 23, 2016
Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled AnalysisXiaoli Ma, Gwénaël Le Teuff, Benjamin Lacas, et al.
Clinical Lung Cancer|September 17, 2021
Treatment Patterns and Outcomes of Patients With Advanced Pleural Mesothelioma at an Academic Referral CentreSabine Schmid, Luna Zhan, Kristen Dietrich, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Repeat Next-Generation Sequencing (15-Gene Panel) in Unifocal, Synchronous, and Metachronous Non-Small-Cell Lung Cancer-A Single-Center ExperienceShelley Kuang, Kaitlin Chen, Sachin Sayal, et al.
Breast Cancer Research : BCR|July 18, 2012
Height, adiposity and body fat distribution and breast density in young womenJoanne F Dorgan, Catherine Klifa, John A Shepherd, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 2, 2013
Epidermal growth factor receptor inhibition in lung cancer: status 2012Fred R Hirsch, Pasi A Jänne, Wilfried E Eberhardt, et al.
Pageof 129